Development and Internal Validation of a New Prognostic Model Powered to Predict 28-Day All-Cause Mortality in ICU COVID-19 Patients-The COVID-SOFA Score

• Published in: Journal of clinical medicine Vol. 11; no. 14; p. 4160
• Main Authors: Moisa, Emanuel, Corneci, Dan, Negutu, Mihai Ionut, Filimon, Cristina Raluca, Serbu, Andreea, Popescu, Mihai, Negoita, Silvius, Grintescu, Ioana Marina
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.07.2022; MDPI
• Subjects: Age; Bias; Clinical medicine; Coronaviruses; COVID-19; Disease; Glasgow Coma Scale; Hospitals; Laboratories; Length of stay; Medical prognosis; Mortality; Nosocomial infections; Pneumonia; Respiratory failure; Sepsis; Severe acute respiratory syndrome coronavirus 2; Ventilators; United States > US; COVID-19; SOFA; prognostic score; SARS-CoV-2; neutrophil-to-lymphocyte ratio; NLR; mortality; ICU; ARDS
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11144160

Background: The sequential organ failure assessment (SOFA) score has poor discriminative ability for death in severely or critically ill patients with Coronavirus disease 2019 (COVID-19) requiring intensive care unit (ICU) admission. Our aim was to create a new score powered to predict 28-day mortality. Methods: Retrospective, observational, bicentric cohort study including 425 patients with COVID-19 pneumonia, acute respiratory failure and SOFA score ≥ 2 requiring ICU admission for ≥72 h. Factors with independent predictive value for 28-day mortality were identified after stepwise Cox proportional hazards (PH) regression. Based on the regression coefficients, an equation was computed representing the COVID-SOFA score. Discriminative ability was tested using receiver operating characteristic (ROC) analysis, concordance statistics and precision-recall curves. This score was internally validated. Results: Median (Q1−Q3) age for the whole sample was 64 [55−72], with 290 (68.2%) of patients being male. The 28-day mortality was 54.58%. After stepwise Cox PH regression, age, neutrophil-to-lymphocyte ratio (NLR) and SOFA score remained in the final model. The following equation was computed: COVID-SOFA score = 10 × [0.037 × Age + 0.347 × ln(NLR) + 0.16 × SOFA]. Harrell’s C-index for the COVID-SOFA score was higher than the SOFA score alone for 28-day mortality (0.697 [95% CI; 0.662−0.731] versus 0.639 [95% CI: 0.605−0.672]). Subsequently, the prediction error rate was improved up to 16.06%. Area under the ROC (AUROC) was significantly higher for the COVID-SOFA score compared with the SOFA score for 28-day mortality: 0.796 [95% CI: 0.755−0.833] versus 0.699 [95% CI: 0.653−0.742, p < 0.001]. Better predictive value was observed with repeated measurement at 48 h after ICU admission. Conclusions: The COVID-SOFA score is better than the SOFA score alone for 28-day mortality prediction. Improvement in predictive value seen with measurements at 48 h after ICU admission suggests that the COVID-SOFA score can be used in a repetitive manner. External validation is required to support these results.